GASTROINTESTINAL STROMAL TUMORS
Clinical trials for GASTROINTESTINAL STROMAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test MS drug to boost cancer treatment before surgery
Disease control Recruiting nowThis early-stage study aims to find a safe dose of fampridine (a multiple sclerosis drug) when combined with the cancer drug imatinib (Gleevec) for patients with a specific type of gastrointestinal stromal tumor (GIST). Researchers want to see if this two-drug combination is more…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
DNA blood test could match cancer patients to best drug
Disease control Recruiting nowThis study is testing whether a simple blood test that looks for cancer DNA can help doctors choose between two standard drugs for advanced gastrointestinal cancer. Researchers want to see if patients with specific DNA changes respond better to one drug versus the other. The goal…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Experimental drug targets multiple advanced cancers in first human test
Disease control Recruiting nowThis early-stage trial is testing a new cancer drug called NN3201 for the first time in people. The study aims to find a safe dose and see how well the drug works against several advanced solid tumors that have a specific protein called c-Kit. Researchers will enroll 67 adults wi…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New study aims to tame harsh cancer drug side effects
Disease control Recruiting nowThis study is testing if closely monitoring the level of the cancer drug imatinib in a patient's blood can help control gastrointestinal stromal tumors (GIST) while causing fewer severe side effects. Researchers will track 28 adults with specific GIST mutations who are starting i…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Reema A. Patel • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Could a phone call replace your cancer check-up?
Disease control Recruiting nowThis study is testing if follow-up care for certain rare cancers can be done just as well remotely by a nurse over the phone, compared to traditional in-person visits with a doctor at the hospital. It aims to see if patients stick to their recommended check-up schedule better wit…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Mar 17, 2026 12:59 UTC
-
Massive cancer database seeks volunteers to help unlock disease secrets
Knowledge-focused Recruiting nowThis study is building a large, long-term database of health information and biological samples from people with cancer, people at risk for cancer, and healthy volunteers. The goal is to collect this data to help researchers better understand what causes cancer and how to prevent…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC